Displaying items by tag: harbert institute for innovation and entrepreneurship

Fobian developed Retraining and Control Therapy, or ReACT, to help patients with functional neurological disorder, or FND, which affects an estimated 300,000 Americans.
Ninety-two percent of evaluable patients treated with INB-200 exceeded a median progression-free survival of seven months. Glioblastoma multiforme is the most aggressive type of cancer originating in the brain.
Awards and honors continue for the PRCA/PRSSA at UAB chapter, where students put their classroom learning into real-world practice, preparing them for careers and vaulting them into the professional world.
UAB received the IEP Innovation award, recognizing exemplary initiatives spurring innovation, entrepreneurship and technology-based economic development.
This new grant will be used to develop a full-scale family of devices for inhaled nitric oxide delivery for patients with pulmonary hypertension that can be used in health care facilities and for at-home care.
The Alabama Innovation Corporation awarded two UAB startups with grants during the second round of Innovate Alabama Supplemental Grant awards.
The panel discussion will help navigate through the daunting, complicated process of launching a startup for passionate entrepreneurs.
The grant validates the science of Alveolus Bio, and the funds will support development of first-of-its-kind inhaled biotherapeutics to treat chronic lung diseases.
The funded project began Jan. 1 and is expected to run for two years. The proposal focuses on developing a novel dental pulp capping material by improving bioactivity of pulp tissue while achieving ideal mechanical properties.
The spinoff company, IN8bio Inc., uses proprietary drug-resistant immunotherapy licensed in part from UAB. Glioblastoma is the most aggressive type of cancer originating in the brain.
The Zorro-Flow Inc. is the newest startup from the UAB Harbert Institute for Innovation and Entrepreneurship. The device is the first external catheter to collect urine effectively, safely and comfortably from critically ill female neonates and children.
Page 1 of 2